ASP9801pembrolizumabadvanced solid tumors
… due to malignant neoplasm progression; none were attributed to ASP9801. One patient in Group B combination safety cohort achieved conf…
1articles mentioning drugs
11drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ASP9801 ×
ASP9801
This drug is selected. Its supporting articles are shown below.